From 21 February 2022, the Novavax COVID-19 vaccine will be available for the primary course of COVID-19 vaccination in people aged 18 or older in Victoria.
The Novavax COVID-19 vaccine was provisionally approved by Therapeutic Goods Administration’s (TGA) on 20 January and has been recommended by the Australian Technical Advisory Group on Immunisation (ATAGI) for people aged 18 years and over.
The Novavax COVID-19 vaccine can be used for the primary course of COVID-19 vaccination in people aged 18 or older. Two doses of the vaccine are recommended, at least three weeks apart.
Novavax is not currently approved for use as a third dose (booster) vaccine, or for people under the age of 18. However, people who are severely immunocompromised are eligible to receive a third primary dose of Novavax as part of their three-dose primary course schedule.
What’s in the Novavax vaccine
Novavax is a protein-based vaccine, unlike Pfizer and Moderna which are mRNA vaccines. Novavax does not contain any live virus and it cannot give you COVID-19.
This type of vaccine contains part of the coronavirus spike protein. Your immune system cells recognise the spike protein as a threat and begin building an immune response against it.
The vaccine can be administered to pregnant and breastfeeding women.
Where to get the Novavax vaccine
To book your vaccine, you can do so online or by calling 1800 675 398.
At Monash Health, Novavax is available (booking only) at our Sandown Racecourse Vaccination Centre.
Frequently asked questions
To answer your most asked questions, please visit our Frequently asked questions webpage.
For further information, you can read more on the Australian Government’s Department of Health website.